Manganese exposure alters extracellular GABA, GABA receptor and transporter protein and mRNA levels in the developing rat brain.
Unlike other essential trace elements (e.g., zinc and iron) it is the toxicity of manganese (Mn) that is more common in human populations than its deficiency. Data suggest alterations in dopamine biology may drive the effects associated with Mn neurotoxicity, though recently gamma-aminobutyric acid (GABA) has been implicated. In addition, iron deficiency (ID), a common nutritional problem, may cause disturbances in neurochemistry by facilitating accumulation of Mn in the brain. Previous data from our lab have shown decreased brain tissue levels of GABA as well as decreased (3)H-GABA uptake in synaptosomes as a result of Mn exposure and ID. These results indicate a possible increase in the concentration of extracellular GABA due to alterations in expression of GABA transport and receptor proteins. In this study weanling-male Sprague-Dawley rats were randomly placed into one of four dietary treatment groups: control (CN; 35mg Fe/kg diet), iron-deficient (ID; 6mg Fe/kg diet), CN with Mn supplementation (via the drinking water; 1g Mn/l) (CNMn), and ID with Mn supplementation (IDMn). Using in vivo microdialysis, an increase in extracellular GABA concentrations in the striatum was observed in response to Mn exposure and ID although correlational analysis reveals that extracellular GABA is related more to extracellular iron levels and not Mn. A diverse effect of Mn exposure and ID was observed in the regions examined via Western blot and RT-PCR analysis, with effects on mRNA and protein expression of GAT-1, GABA(A), and GABA(B) differing between and within the regions examined. For example, Mn exposure reduced GAT-1 protein expression by approximately 50% in the substantia nigra, while increasing mRNA expression approximately four-fold, while in the caudate putamen mRNA expression was decreased with no effect on protein expression. These data suggest that Mn exposure results in an increase in extracellular GABA concentrations via altered expression of transport and receptor proteins, which may be the basis of the neurological characteristics of manganism.
Anderson
Joel G
JG
Department of Nutrition, University of North Carolina at Greensboro, Greensboro, NC 27402, USA.
Fordahl
Steve C
SC
Cooney
Paula T
PT
Weaver
Tara L
TL
Colyer
Christa L
CL
Erikson
Keith M
KM
D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000187:drug effects* / Q000254:growth & development; D045604:Extracellular Fluid / Q000187:drug effects* / Q000378:metabolism; D050485:GABA Plasma Membrane Transport Proteins / Q000235:genetics / Q000378:metabolism*; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects*; D008297:Male; D008345:Manganese / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018079:Receptors, GABA / Q000235:genetics / Q000378:metabolism*; D014131:Trace Elements / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D050485:GABA Plasma Membrane Transport Proteins; D012333:RNA, Messenger; D018079:Receptors, GABA; D014131:Trace Elements; D008345:Manganese; D005680:gamma-Aminobutyric Acid
Environ Toxicol Pharmacol. 2007 Mar;23(2):179-84
17387379
Nat Neurosci. 1999 May;2(5):467-72
10321252
Acta Pharmacol Toxicol (Copenh). 1976;39(5):562-9
990038
Anal Bioanal Chem. 2005 Jun;382(3):581-91
15726336
Trends Neurosci. 1990 Jul;13(7):259-65
1695400
J Nutr. 2001 Feb;131(2S-2):568S-579S; discussion 580S
11160590
Arch Toxicol. 1976 Aug 18;35(4):319-23
989299
J Neurosci. 2008 Jan 30;28(5):1185-97
18234896
Neurotoxicology. 1999 Apr-Jun;20(2-3):467-76
10385905
Biophys J. 1986 Oct;50(4):669-76
3779006
Am J Ind Med. 2007 Oct;50(10):772-8
17620281
Neurotoxicology. 2004 Mar;25(3):433-41
15019306
Biometals. 2003 Mar;16(1):41-54
12572663
Neurochem Int. 2002 Oct;41(4):271-7
12106778
Neurochem Res. 1999 Jul;24(7):849-56
10403624
Environ Res. 1994 Feb;64(2):151-80
8306949
J Neurosci. 2005 Mar 23;25(12):3234-45
15788781
Brain Res Bull. 1999 Oct;50(3):209-14
10566983
Biol Trace Elem Res. 2002 Summer;87(1-3):143-56
12117224
Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):409-18
11509198
J Nutr. 2000 Aug;130(8):2040-8
10917923
Trends Neurosci. 1990 Jul;13(7):272-6
1695402
Experientia. 1989 Apr 15;45(4):343-5
2565248
FEBS Lett. 2001 Dec 7;509(2):309-16
11741608
Brain Res Brain Res Rev. 1998 May;26(2-3):148-53
9651511
Neurotoxicology. 2002 May;23(1):69-76
12164549
J Nutr. 1992 Jun;122(6):1300-8
1588448
Trends Pharmacol Sci. 2006 Jul;27(7):375-83
16762425
Neurosci Lett. 1999 Aug 13;271(1):5-8
10471200
J Neurochem. 1999 Jan;72(1):148-56
9886065
J Neurochem. 2006 Apr;97(2):310-33
16539676
Biochem Pharmacol. 2003 Jul 1;66(1):1-13
12818360
J Nutr Biochem. 2004 Jun;15(6):335-41
15157939
Arch Environ Health. 1989 May-Jun;44(3):175-8
2751354
J Nutr. 1997 Dec;127(12):2282-8
9405575
Toxicol Sci. 2007 Jan;95(1):205-14
17060373
Environ Toxicol Pharmacol. 2005 Nov;20(3):390-4
21783617
Neurosci Lett. 2003 Sep 25;349(1):13-6
12946575
J Nutr. 2000 Nov;130(11):2831-7
11053528
Environ Health Perspect. 2006 Jan;114(1):124-9
16393669
Am J Clin Nutr. 1999 Jul;70(1):37-43
10393136
Hokkaido Igaku Zasshi. 1998 May;73(3):215-25
9719948
Toxicol Sci. 2007 Jan;95(1):188-95
17032702
Neuroreport. 2005 Feb 28;16(3):307-10
15706241
Neurochem Res. 2005 Sep;30(9):1147-54
16292508
Neurosci Lett. 2006 May 1;398(1-2):151-4
16417967
Crit Rev Toxicol. 2005 Jan;35(1):1-32
15742901
J Pharmacol Exp Ther. 2005 Apr;313(1):46-55
15608081
J Neurosci Res. 2001 Mar 15;63(6):461-8
11241581
Toxicol Sci. 2006 Aug;92(2):516-25
16705042
Nature. 1997 Jul 31;388(6641):482-8
9242408
Prog Brain Res. 2007;160:43-57
17499108
Neuroscience. 1999;93(3):1189-96
10473284
J Chromatogr A. 2001 Apr 20;914(1-2):293-8
11358224
J Neurochem. 1994 Jan;62(1):205-16
7505311
Pharmacol Ther. 1995;67(2):187-246
7494864
Pharmacol Ther. 2001 Oct;92(1):21-55
11750035
Neurotoxicology. 1999 Apr-Jun;20(2-3):227-38
10385886